Company Quick10K Filing
BioRestorative Therapies
10-Q 2021-03-31 Filed 2021-05-17
10-K 2020-12-31 Filed 2021-04-30
10-Q 2020-09-30 Filed 2021-04-12
10-Q 2020-06-30 Filed 2021-04-12
10-Q 2020-03-31 Filed 2021-03-29
10-K 2019-12-31 Filed 2021-03-18
10-Q 2019-09-30 Filed 2019-11-13
10-Q 2019-06-30 Filed 2019-08-14
S-1 2019-04-26 Public Filing
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-22
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-04-11
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-19
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-02
10-Q 2012-09-30 Filed 2012-11-05
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-17
8-K 2020-11-16
8-K 2020-10-30
8-K 2020-04-23
8-K 2020-03-30
8-K 2020-03-16
8-K 2020-02-28
8-K 2020-02-20
8-K 2020-02-20
8-K 2020-02-13
8-K 2020-02-11
8-K 2020-02-03
8-K 2020-01-27
8-K 2020-01-20
8-K 2020-01-10
8-K 2020-01-08
8-K 2019-12-31
8-K 2019-12-19
8-K 2019-12-12
8-K 2019-12-02
8-K 2019-11-20
8-K 2019-11-13
8-K 2019-11-01
8-K 2019-10-30
8-K 2019-10-16
8-K 2019-10-07
8-K 2019-09-30
8-K 2019-08-30
8-K 2019-08-21
8-K 2019-07-26
8-K 2019-07-11
8-K 2019-06-18
8-K 2019-06-06
8-K 2019-05-30
8-K 2019-05-22
8-K 2019-05-07
8-K 2019-04-30
8-K 2019-04-18
8-K 2019-02-19
8-K 2019-02-06
8-K 2019-01-22
8-K 2019-01-04
8-K 2018-12-21
8-K 2018-12-13
8-K 2018-11-20
8-K 2018-10-28
8-K 2018-10-15
8-K 2018-10-04
8-K 2018-09-20
8-K 2018-09-06
8-K 2018-08-31
8-K 2018-08-21
8-K 2018-08-06
8-K 2018-06-27
8-K 2018-05-31
8-K 2018-05-24
8-K 2018-01-16
8-K 2018-01-12

BioRestorative Therapies Financials

BRTX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash15723131040499012011105937492146613167353516632921452941051184961,28498
Accounts Receivable519391656720163819372629293138
Inventory12141418181818172222
PP&E33195697969165504133177261874652537702663941599602556950463417370954286257214865141136106
Assets403221881,3421,3971,2681,7761,2501,2241,3831,2531,1861,5961,6921,8582,0712,1512,0172,0492,1961,6171,5801,4811,4241,4191,7591,2231,2061,2511,1921,5842,4321,458
Accounts Payable6584267394407007717731,0031,1561,2701,2038937741,1121,2661,7472,1102,5492,1942,0701,9942,2842,2842,4672,7182,4552,3862,2772,1121,8941,5681,5271,744
Long-Term Debt3,5943,5553,6320524275776238330830422302049948729813812062194843691,191524488201157
Liabilities3,7473,9074,4145,6006,4756,4106,6146,9867,8588,0688,2368,3358,0548,5809,2534,9515,9275,9255,5906,2016,0886,5806,2027,1398,1098,5958,91411,07410,1899,8339,23711,37513,887
Stockholders' Equity-3,344-3,686-4,326-4,258-5,078-5,142-4,838-5,736-6,634-6,685-6,983-7,149-6,458-6,888-7,395-2,881-3,776-3,908-3,541-4,005-4,471-5,000-4,722-5,715-6,690-6,837-7,690-9,868-8,938-8,641-7,653-8,942-12,429
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0001050100001761608018514996199916567221638194026293138
Cost of Revenue100000042661057675516000000000
Gross Profit401000013494-261087445140916567221638
R&D12255190170400373415406494372291353407452616630866609656753806760491245407373357455442410
SG&A5122263994022702866706015315786687015456079637456371,6949251,0016267921,2261,7037458941,4101,9614401,3031,1841,073
Tax000
Net Income-1,013-743-1,494-1,646-1,477-1,919-1,566-1,251-1,303-1,631-1,670-1,333-1,100-1,484-1,760-1,420-1,624-3,119-2,487-2,258-1,834-2,057-2,786-2,747-2,052-1,860-2,508-3,514-2,925-3,883-4,157-5,057
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1,116-394-1,257-451-1,083-772-702-434-764-807-834-634-675-810-584-1,054-1,718-1,018-1,206-1,062-1,219-766-509-1,360-1,158-1,353-1,980-1,417-1,711
Cash Investing0-1,00300000-111-2-167-167-60-209-48-90-61-31-7000-40-6
Cash Financing1,1723262,2695429791,2702044359757151,1505198967307991,2551,9941,2427261,0941,1967595081,8147151,4552,3592,234531